Repare Therapeutics Inc RPTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
3.45quote price arrow up+0.10 (+2.99%)
Volume
173,217
52 week range
2.98 - 13.85
Loading...
  • Open3.48
  • Day High3.74
  • Day Low3.44
  • Prev Close3.35
  • 52 Week High13.85
  • 52 Week High Date09/20/23
  • 52 Week Low2.98
  • 52 Week Low Date04/19/24

Key Stats

  • Market Cap145.529M
  • Shares Out42.18M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta0.68
  • YTD % Change-52.74

KEY STATS

  • Open3.48
  • Day High3.74
  • Day Low3.44
  • Prev Close3.35
  • 52 Week High13.85
  • 52 Week High Date09/20/23
  • 52 Week Low2.98
  • 52 Week Low Date04/19/24
  • Market Cap145.529M
  • Shares Out42.18M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta0.68
  • YTD % Change-52.74

RATIOS/PROFITABILITY

  • EPS (TTM)-2.23
  • P/E (TTM)-1.55
  • Fwd P/E (NTM)-1.27
  • EBITDA (TTM)-114.273M
  • ROE (TTM)-38.16%
  • Revenue (TTM)51.133M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-183.44%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Repare Therapeutics Inc

 

Profile

MORE
Repare Therapeutics Inc. is a clinical-stage precision oncology company focused on the development of synthetic lethality (SL)-based therapies for patients with cancer. The Company is engaged in the proprietary SL approach to the discovery and development of novel therapeutics. It uses its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop cancer therapies focused on genomic instability, including deoxyribonucleic acid (DNA) damage repair. The...
Thomas Civik
Independent Chairman of the Board
Lloyd Segal
President, Chief Executive Officer, Director
Steve Forte
Chief Financial Officer, Executive Vice President
Maria Koehler M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Michael Zinda Ph.D.
Executive Vice President, Chief Scientific Officer
Address
7210 Frederick-Banting, Suite 100
St-laurent, QC
H4S 2A1
Canada

Top Peers

SYMBOLLASTCHG%CHG
PLX
Protalix Biotherapeutics Inc
1.14-0.02-1.72%
BCYC
Bicycle Therapeutics PLC
24.58-0.11-0.45%
RCEL
AVITA Medical Inc
8.75+0.03+0.34%
DTIL
Precision BioSciences Inc
10.52-0.32-2.95%
TKNO
Alpha Teknova Inc
1.90-0.04-1.81%